The Discounted Cash Flow (DCF) valuation of Collegium Pharmaceutical Inc (COLL) is 55.99 USD. With the latest stock price at 22.02 USD, the upside of Collegium Pharmaceutical Inc based on DCF is 154.3%.
Based on the latest price of 22.02 USD and our DCF valuation, Collegium Pharmaceutical Inc (COLL) is a buy. buying COLL stocks now will result in a potential gain of 154.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 8.2% | 6.9% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 22.84 - 187.90 | 55.99 |
| Upside | 3.7% - 753.3% | 154.3% |